Short answer
CATALYST PHARMACEUTICALS, INC. (CPRX) filed an 8-K current report with the SEC on May 11, 2026 reporting Item 8.01 (Other Events). Q1 2026 operating results and business update announced for the three months ended March 31, 2026.
CATALYST PHARMACEUTICALS, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- Q1 2026 operating results and business update announced for the three months ended March 31, 2026
- Exhibit 99.1 contains the detailed financial results and management commentary
- Investor focus: revenue, profitability, Firdapse growth, and updated business outlook in the attached release
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other CATALYST PHARMACEUTICALS, INC. 8-K filings
Get the next CPRX 8-K as it lands
Follow CPRX for push alerts, or ask the research agent what this filing means.